MD, Carol Davila University of Medicine and Pharmacy
MS, Carol Davila University of Medicine and Pharmacy

Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.

  1. Christmann RB, Mathes A, Affandi AJ, Padilla C, Nazari B, Bujor AM, Stifano G, Lafyatis R. Thymic stromal lymphopoietin is up-regulated in the skin of patients with systemic sclerosis and induces profibrotic genes and intracellular signaling that overlap with those induced by interleukin-13 and transforming growth factor ß. Arthritis Rheum. 2013 May; 65(5):1335-46.View Related Profiles. PMID: 23335246; DOI: 10.1002/art.37859;.
  2. Bujor AM, Haines P, Padilla C, Christmann RB, Junie M, Sampaio-Barros PD, Lafyatis R, Trojanowska M. Ciprofloxacin has antifibrotic effects in scleroderma fibroblasts via downregulation of Dnmt1 and upregulation of Fli1. Int J Mol Med. 2012 Dec; 30(6):1473-80.View Related Profiles. PMID: 23041765; DOI: 10.3892/ijmm.2012.1150;.
  3. Haines P, Hant FN, Lafyatis R, Trojanowska M, Bujor AM. Elevated expression of cav-1 in a subset of SSc fibroblasts contributes to constitutive Alk1/Smad1 activation. J Cell Mol Med. 2012 Sep; 16(9):2238-46.View Related Profiles. PMID: 22277251; PMCID: PMC3822993; DOI: 10.1111/j.1582-4934.2012.01537.x;.
  4. Samuel GH, Lenna S, Bujor AM, Lafyatis R, Trojanowska M. Acid sphingomyelinase deficiency contributes to resistance of scleroderma fibroblasts to Fas-mediated apoptosis. J Dermatol Sci. 2012 Sep; 67(3):166-72.View Related Profiles. PMID: 22771321; PMCID: PMC3423203; DOI: 10.1016/j.jdermsci.2012.06.001;.
  5. Morris E, Chrobak I, Bujor A, Hant F, Mummery C, Ten Dijke P, Trojanowska M. Endoglin promotes TGF-ß/Smad1 signaling in scleroderma fibroblasts. J Cell Physiol. 2011 Dec; 226(12):3340-8.View Related Profiles. PMID: 21344387; PMCID: PMC3381731; DOI: 10.1002/jcp.22690;.
  6. Haines P, Samuel GH, Cohen H, Trojanowska M, Bujor AM. Caveolin-1 is a negative regulator of MMP-1 gene expression in human dermal fibroblasts via inhibition of Erk1/2/Ets1 signaling pathway. J Dermatol Sci. 2011 Dec; 64(3):210-6.View Related Profiles. PMID: 21925842; PMCID: PMC3826600; DOI: 10.1016/j.jdermsci.2011.08.005;.
  7. Nakerakanti SS, Bujor AM, Trojanowska M. CCN2 is required for the TGF-ß induced activation of Smad1-Erk1/2 signaling network. PLoS One. 2011; 6(7):e21911.View Related Profiles. PMID: 21760921; PMCID: PMC3132735; DOI: 10.1371/journal.pone.0021911;.
  8. Bujor AM, Asano Y, Haines P, Lafyatis R, Trojanowska M. The c-Abl tyrosine kinase controls protein kinase Cd-induced Fli-1 phosphorylation in human dermal fibroblasts. Arthritis Rheum. 2011 Jun; 63(6):1729-37.View Related Profiles. PMID: 21321929; PMCID: PMC3381734; DOI: 10.1002/art.30284;.
  9. Samuel GH, Bujor AM, Nakerakanti SS, Hant FN, Trojanowska M. Autocrine transforming growth factor ß signaling regulates extracellular signal-regulated kinase 1/2 phosphorylation via modulation of protein phosphatase 2A expression in scleroderma fibroblasts. Fibrogenesis Tissue Repair. 2010; 3:25.View Related Profiles. PMID: 21134273; PMCID: PMC3008687; DOI: 10.1186/1755-1536-3-25;.
  10. Asano Y, Bujor AM, Trojanowska M. The impact of Fli1 deficiency on the pathogenesis of systemic sclerosis. J Dermatol Sci. 2010 Sep; 59(3):153-62.View Related Profiles. PMID: 20663647; PMCID: PMC3826615; DOI: 10.1016/j.jdermsci.2010.06.008;.
Showing 10 of 13 results. Show More

This graph shows the total number of publications by year, by first, middle/unknown, or last author.

Contact for Mentoring: